Description
AllerGene AI Therapeutics is a biotechnology company developing innovative cell and gene therapy approaches for severe allergic diseases, mast cell disorders, and anaphylaxis. Its investigational platform uses in vivo mRNA CAR-T technology designed to selectively target mast cells and explore a potential new approach to resetting allergic immune responses. AllerGene also develops AI-powered research tools to support biomedical research and development insights.
Categories
Contact Information
- investors@allergeneai.info
- https://allergene.ai/
Add a review